- Home
- CRON vs CGEM Comparison
CRON vs CGEM Comparison
Compare CRON & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRON
- CGEM
- Stock Information
- Founded
- CRON 2012
- CGEM 2016
- Country
- CRON Canada
- CGEM United States
- Employees
- CRON N/A
- CGEM N/A
- Industry
- CRON Medicinal Chemicals and Botanical Products
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- CRON Health Care
- CGEM Health Care
- Exchange
- CRON Nasdaq
- CGEM Nasdaq
- Market Cap
- CRON 737.8M
- CGEM 730.2M
- IPO Year
- CRON N/A
- CGEM 2021
- Fundamental
- Price
- CRON $1.99
- CGEM $10.26
- Analyst Decision
- CRON Hold
- CGEM Strong Buy
- Analyst Count
- CRON 2
- CGEM 7
- Target Price
- CRON $3.00
- CGEM $31.67
- AVG Volume (30 Days)
- CRON 1.5M
- CGEM 614.7K
- Earning Date
- CRON 02-27-2025
- CGEM 03-13-2025
- Dividend Yield
- CRON N/A
- CGEM N/A
- EPS Growth
- CRON N/A
- CGEM N/A
- EPS
- CRON N/A
- CGEM N/A
- Revenue
- CRON $111,229,000.00
- CGEM N/A
- Revenue This Year
- CRON $40.73
- CGEM N/A
- Revenue Next Year
- CRON $18.84
- CGEM N/A
- P/E Ratio
- CRON N/A
- CGEM N/A
- Revenue Growth
- CRON 30.31
- CGEM N/A
- 52 Week Low
- CRON $1.86
- CGEM $9.50
- 52 Week High
- CRON $3.14
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- CRON 48.78
- CGEM 34.25
- Support Level
- CRON $1.93
- CGEM $9.50
- Resistance Level
- CRON $2.01
- CGEM $11.31
- Average True Range (ATR)
- CRON 0.07
- CGEM 0.77
- MACD
- CRON 0.00
- CGEM -0.11
- Stochastic Oscillator
- CRON 34.83
- CGEM 21.79
About CRON Cronos Group Inc. Common Share
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.